Dr. Vijay Pandyarajan, MD, PhD

Dr. Pandyarajan practices at Cedars-Sinai Medical Center in Los Angeles, California, part of Cedars-Sinai Health System.

Dr. Pandyarajan's NPI, 1083068340, was assigned on April 22, 2016. Dr. Pandyarajan graduated from Cleveland Medical College, Homeopathic in 2016. Dr. Pandyarajan's California license number on file is A153821.

Dr. Pandyarajan's primary practice is Cedars-Sinai Medical Center, at 8700 Beverly Blvd, Los Angeles, CA 90048 in Los Angeles County. The practice phone is (310) 423-5000.

Dr. Pandyarajan's primary practice is Cedars-Sinai Medical Center in Los Angeles, California, part of Cedars-Sinai Health System. The medical group on file is TeleMed2U. Dmand AI also links Dr. Pandyarajan to 2 more group practices and clinics and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Pandyarajan practices, 3 sites in all. Vendor and product names are available with a free account.

Gastroenterology is Dr. Pandyarajan's primary specialty in the NPI Registry, under taxonomy code 207RG0100X. Dr. Pandyarajan is board certified in gastroenterology by the American Board of Internal Medicine. Dr. Pandyarajan has a license on file in California.

Dmand AI lists fatty liver and upper GI endoscopy among the conditions Dr. Pandyarajan treats.

CMS data shows 270 Medicare services from Dr. Pandyarajan across 5 procedure codes in 2024, for 133 Medicare patients. Medicare paid $12,535 for them. Every service was in an office.

CMS counts 133 Medicare patients who saw Dr. Pandyarajan in 2024. The largest group is 65 to 74, with 64 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 33% are also on Medicaid. Their average risk score is 1.41, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Pandyarajan's median patient age at 61, with 59% women.

In 2024, Dr. Pandyarajan wrote 19 Medicare Part D claims. They cover 1 drug, with $35,726 in total drug cost.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 93 out of 100 for Dr. Pandyarajan for performance year 2024, reported as part of a group. Dr. Pandyarajan accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Pandyarajan as offering telehealth.

Colonoscopy: 1 to 10 procedures (CMS shows small counts as a range)

Upper gastrointestinal (GI) endoscopy for acid reflux: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 8 papers to Dr. Pandyarajan, published from 2014 to 2020. 2014 was the busiest year, with 3. The most frequent topics are Insulin, Receptor, Insulin and Models, Molecular. Dr. Pandyarajan has published most often in J Biol Chem. Dr. Pandyarajan's most frequent co-authors are Michael Lawrence, MD, Faramarz N. Ismail-Beigi, MD and Robert Gareth Gish, MD.

CMS Open Payments shows 3 general payments to Dr. Pandyarajan from 2 drug and device companies from 2024 to 2025. Food and beverage make up the largest share, 100% of the total. Madrigal Pharmaceuticals paid the most, $139.

Dr. Pandyarajan graduated from Cleveland Medical College, Homeopathic in 2016.

Dr. Pandyarajan is in network with 13 carriers, including Aetna, Elevance and Blue Cross Blue Shield of Michigan. PPO plans come from the most carriers, 9. Check the plan with the practice before a visit.